Inspira Technologies OXY B.H.N. (NASDAQ:QTEX) Releases Earnings Results

Inspira Technologies OXY B.H.N. (NASDAQ:QTEX) issued its earnings results on Thursday. The company reported ($0.07) earnings per share for the quarter, FiscalAI reports. The firm had revenue of $0.78 million during the quarter.

Inspira Technologies OXY B.H.N. Price Performance

Shares of QTEX stock opened at $0.78 on Friday. The company has a quick ratio of 1.30, a current ratio of 1.56 and a debt-to-equity ratio of 0.08. Inspira Technologies OXY B.H.N. has a 1-year low of $0.28 and a 1-year high of $3.85. The business’s fifty day moving average is $0.90.

Inspira Technologies OXY B.H.N. declared that its board has approved a share buyback plan on Monday, June 22nd that authorizes the company to buyback 2,000,000,000,000 outstanding shares. This buyback authorization authorizes the company to purchase up to 5.6% of its stock through open market purchases. Stock buyback plans are often a sign that the company’s board of directors believes its stock is undervalued.

Wall Street Analyst Weigh In

Several brokerages recently commented on QTEX. Wall Street Zen lowered Inspira Technologies OXY B.H.N. from a “hold” rating to a “sell” rating in a research report on Saturday, August 8th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Inspira Technologies OXY B.H.N. in a research report on Monday, August 24th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company currently has an average rating of “Sell”.

Inspira Technologies OXY B.H.N. Company Profile

Inspira Technologies OXY B.H.N. Ltd. is an Israeli medical technology company focused on developing advanced respiratory-support systems for patients experiencing acute respiratory failure. The company’s technology is intended to support blood oxygenation and carbon-dioxide removal while potentially reducing reliance on invasive mechanical ventilation.

Its principal product platform is the INSPIRA ART system, an extracorporeal respiratory-support technology designed to oxygenate blood outside the body and return it to the patient.